BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23719950)

  • 1. Analysis of circulating microRNA by microarray in liver disease.
    Murakami Y; Tanahashi T
    Methods Mol Biol; 2013; 1024():173-82. PubMed ID: 23719950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of extraction reagent and DNA microarray that allows for the detection of global miRNA profiles from serum/plasma.
    Ichikawa M; Akiyama H
    Methods Mol Biol; 2013; 1024():247-53. PubMed ID: 23719957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients.
    Dai Y; Huang YS; Tang M; Lv TY; Hu CX; Tan YH; Xu ZM; Yin YB
    Lupus; 2007; 16(12):939-46. PubMed ID: 18042587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
    Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
    Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray analysis of miRNA gene expression.
    Thomson JM; Parker JS; Hammond SM
    Methods Enzymol; 2007; 427():107-22. PubMed ID: 17720481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for microRNA microarray profiling.
    Ranade AR; Weiss GJ
    Methods Mol Biol; 2011; 700():145-52. PubMed ID: 21204032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
    Sukata T; Sumida K; Kushida M; Ogata K; Miyata K; Yabushita S; Uwagawa S
    Toxicol Lett; 2011 Jan; 200(1-2):46-52. PubMed ID: 21035526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular microRNA: a new source of biomarkers.
    Etheridge A; Lee I; Hood L; Galas D; Wang K
    Mutat Res; 2011 Dec; 717(1-2):85-90. PubMed ID: 21402084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of microRNAs in prostate cancer cells by microRNA array.
    Tang X; Tang X; Gal J; Kyprianou N; Zhu H; Tang G
    Methods Mol Biol; 2011; 732():69-88. PubMed ID: 21431706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular miRNAs: the mystery of their origin and function.
    Turchinovich A; Weiz L; Burwinkel B
    Trends Biochem Sci; 2012 Nov; 37(11):460-5. PubMed ID: 22944280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic microRNAs in stage II colon cancer.
    Schepeler T; Reinert JT; Ostenfeld MS; Christensen LL; Silahtaroglu AN; Dyrskjøt L; Wiuf C; Sørensen FJ; Kruhøffer M; Laurberg S; Kauppinen S; Ørntoft TF; Andersen CL
    Cancer Res; 2008 Aug; 68(15):6416-24. PubMed ID: 18676867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases.
    Machida A; Ohkubo T; Yokota T
    Methods Mol Biol; 2013; 1024():203-9. PubMed ID: 23719953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
    Qin B; Huang F; Liang Y; Yang Z; Zhong R
    J Gastroenterol Hepatol; 2013 Mar; 28(3):543-50. PubMed ID: 23173724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanopore single-molecule detection of circulating microRNAs.
    Gu LQ; Wang Y
    Methods Mol Biol; 2013; 1024():255-68. PubMed ID: 23719958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.
    Kuwabara Y; Ono K; Horie T; Nishi H; Nagao K; Kinoshita M; Watanabe S; Baba O; Kojima Y; Shizuta S; Imai M; Tamura T; Kita T; Kimura T
    Circ Cardiovasc Genet; 2011 Aug; 4(4):446-54. PubMed ID: 21642241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and clinical implications of microRNAs in hepatocellular carcinoma.
    Zhao X; Yang Z; Li G; Li D; Zhao Y; Wu Y; Robson SC; He L; Xu Y; Miao R; Zhao H
    Sci China Life Sci; 2012 Oct; 55(10):906-19. PubMed ID: 23108868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.
    Blondal T; Jensby Nielsen S; Baker A; Andreasen D; Mouritzen P; Wrang Teilum M; Dahlsveen IK
    Methods; 2013 Jan; 59(1):S1-6. PubMed ID: 23036329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.